The adipocyte is central to organismal metabolism and exhibits significant functional and morphological plasticity during its formation and lifespan. Remarkable transformations of this cell occur during obesity and lactation, and thus it is essential to gain a better understanding of adipocyte function in these two metabolic processes. Considering the critical importance of the cellular organelle endoplasmic reticulum (ER) in adapting to fluctuations in synthetic processes, we explored the role of XBP1, a central regulator of ER adaptive responses, in adipocyte formation and function. Unexpectedly, deletion of adipocyte-XBP1 in vivo in mice (XBP1 DAd ) had no effect on adipocyte formation or on systemic homeostatic metabolism in mice fed a a regular or high-fat diet. However, during lactation, XBP1
INTRODUCTION
The fat cell, or adipocyte, is a central regulator of metabolism that is conserved in organisms ranging from flies to humans. At the core of the adipocyte's function is its ability to store and release lipid in flux with the energy demands of the organism. As such, the life of the adipocyte encompasses many extreme fluctuations in lipid storage capacity, beginning with the development of a preadipocyte into a mature adipocyte, and then continuing to respond to metabolic signals. For example, the adipocyte must deplete its lipid supply under nutrient-scarce or high-energy-demand states such as starvation or lactation, or increase its lipid stores under nutrient-rich conditions, including obesity (Attie and Scherer, 2009 ).
In previous studies we showed that under obese conditions, adipose tissue function is compromised, possibly due to the upregulation of inflammatory and/or endoplasmic reticulum (ER) stress signaling resulting from disruption of the functional integrity of this organelle and activation of its unfolded protein response (UPR). Indeed, in both mice and humans the UPR was activated in adipose tissue in obesity (Hotamisligil, 2010) . One specific molecule identified in these studies was X-box binding protein 1 (XBP1), a transcription factor that is involved in the most ancient arm of the UPR. The UPR transmembrane sensor inositol-requiring enzyme 1a (IRE1a) functions upon activation as an endoribonuclease to cleave 26 bp from the messenger RNA (mRNA) of XBP1. This spliced form of XBP1 (sXBP1) encodes an active transcription factor that upregulates target genes involved in a myriad of ER-related processes, including protein synthesis, protein folding, ER-associated degradation, and ER expansion (Ron and Walter, 2007) . In addition to its role in ER stress, XBP1 is known to be essential for the in vivo differentiation of various secretory cell types, such as plasma cells and pancreatic and salivary exocrine cells (Glimcher, 2010) . Recently, experimental suppression of XBP1 in preadipocyte cell lines was reported to result in incomplete adipogenesis in vitro (Basseri et al., 2009; Sha et al., 2009 ). However, the role of XBP1 in adipocytes in vivo remains unknown. Since adipose tissue XBP1 expression is increased in mouse and human obesity, characterized by robust expansion of adipose tissue, we set out to interrogate the biology of this molecule under conditions that represent extremes of adipose tissue fluctuation (namely, obesity and lactation) in vivo.
We found that, in contrast to expectations, genetic deletion of adipocyte XBP1 did not affect adipose tissue formation and function under homeostatic metabolic conditions. However, we report that XBP1 plays an unanticipated role in regulating adipose tissue function during the homeorhetic, or directional, metabolism of lactation.
RESULTS

In Vivo Deletion of Adipocyte XBP1
We began our study by suppressing Xbp1 expression in cultured adipocytes, and observed an inhibition of differentiation as reported previously (Figures 1A-1C ; Sha et al., 2009 ). However, this function of XBP1 was limited in vitro and the inhibitory effect on adipocyte differentiation could be overcome by stronger stimuli that promote adipogenesis, such as thiazolidinediones ( Figures 1B and 1C) . Therefore, we utilized adipocyte-specific deletion models of XBP1 to investigate the formation and function of adipocytes in a physiological context in vivo in mice. The loxP-Cre system utilizing Cre under the aP2 promoter efficiently deleted XBP1 in adipose tissue at both the mRNA and protein levels ( Figures 1D and S1A) . We next performed a metabolic characterization of the mice harboring adipocyte deletion of XBP1 (XBP1 DAd ). Compared with wild-type (WT) mice, deletion of adipocyte XBP1 did not affect body weight, adipose tissue mass, serum insulin, or glucose homeostasis when the mice were fed a regular chow diet (Figures S1B-S1G). Interestingly, when animals were challenged with a highfat diet (HFD), representing one extreme of adipocyte plasticity and function, body weight and adiposity were still unaltered ( Figures 1E-1G ). In addition, no differences were found in adipose-tissue morphology, serum insulin, serum adiponectin, or systemic glucose tolerance between WT and XBP1 DAd mice ( Figures 1H-1K ). These results indicate that in mice, XBP1 is not a contributing factor to the formation or expansion of adipose tissue and, moreover, it does not regulate adipocyte function or glucose homeostasis under the stress of obesity.
XBP1 Is Regulated during Lactation in Adipocytes
Next, we tested another extreme condition of adipocyte transformation: lactation. Throughout pregnancy, maternal body weight increases, and after parturition, lactation commences and adipose-tissue lipid stores are utilized as components of milk or energy sources for its production. In order to achieve this partitioning of nutrients, adipocytes undergo a dramatic transformation involving severe lipid depletion and suppression of glucose and lipid uptake. Although this phenomenon has been observed morphologically (Elias et al., 1973) , little is known about the functional role of the adipocyte during lactation or the molecular mediators that are involved in this process.
To determine the potential relevance of XBP1 to adipocytes during lactation, we examined the regulation of Xbp1 expression in vivo in adipose tissue during pregnancy and throughout lactation. In gonadal adipose tissue, a depot that is devoid of mammary gland, we observed significant upregulation of total and spliced forms of Xbp1 mRNA during lactation, but not during pregnancy, corresponding to the time of substantial adipocyte transformation ( Figure 2A ). We also observed increased total, but not spliced, Xbp1 mRNA in the inguinal adipose depot, which develops into mammary gland during lactation ( Figure S2A ). In order to explore XBP1 regulation further, we treated cultured adipocytes with prolactin, the primary lactogenic hormone that orchestrates milk production ( Figures 2B and 2C ). Previous studies identified the prolactin receptor on mouse and human adipocytes and showed that its expression increases in adipose tissue during lactation (Flint et al., 2003; Ling et al., 2000) . We found that exposure of adipocytes to prolactin in vitro resulted in increased total and spliced Xbp1 expression (Figures 2B and 2C) , which was similar to the patterns seen in lactating tissues in vivo. The effect of prolactin in adipocytes also revealed no changes or mild increases in other UPR markers. These results warrant further investigation into the role of the UPR in adipocytes during lactation and may suggest a potentially distinctive role for adipocyte XBP1.
Loss of Adipocyte XBP1 Disturbs Lactational Metabolism Interestingly, we observed that when XBP1
DAd dams underwent lactation, they displayed an increase in adiposity compared with WT controls (Figures 2D and 2E ). Under normal conditions, the metabolic characteristics of female XBP1 DAd mice, such as body weight, adipose tissue weight, blood glucose, and serum insulin and lipid levels, were similar to those of the WT controls (Table S1 ). In addition, during pregnancy, no significant differences were observed between WT and XBP1 DAd dams in terms of body weight, blood glucose and insulin levels, litter weights upon delivery, or number of pups per litter ( Figures S2B-S2F ). Food intake during pregnancy and lactation was also similar between WT and XBP1 DAd dams ( Figures S2G and S2H ).
However, during lactation, adipose tissue mass was significantly increased in the XBP1
DAd dams but remained low in the WT dams compared with nonpregnant (NonPG) mice ( Figures  2D and 2E ). We also observed elevated serum insulin and leptin levels, and a trend toward increased total body weight in XBP1 DAd dams, again indicating higher adiposity (Figures 2F and S2I) . Strikingly, litters from XBP1 DAd dams gained less weight during lactation than those from WT dams ( Figure 2G ). Therefore, we thought it critical to examine whether the maternal or fetal genotype was the driver of this phenotype and whether WT dams could rescue this effect. For this purpose, we performed cross-fostering experiments. Nursing of XBP1 DAd pups by WT dams completely rescued the pup phenotype and, conversely, WT pups nursed by XBP1 DAd dams showed a significant decrease in body weight during lactation ( Figure 2H ). These experiments demonstrated that the effect on pup weight resulted from the mother's genotype during lactation and was not the result of an in utero effect. Taken together, these results indicate that lactating XBP1 DAd dams harbor increased adipose tissue lipid stores, and insufficient nutrients reach the pups during lactation.
XBP1 Contribution to Lactation Performance is Adipocyte Specific
Because the participation of adipocytes in the metabolic transition of lactation was an unexpected finding, it was critical to ensure that the observed effects arose from adipocyte XBP1 deficiency per se. Inguinal adipocytes are in close proximity to the mammary gland during lactation because they share the same depot. In contrast, visceral and gonadal adipose tissues do not contain any mammary gland. To verify the specificity of the adipocyte deletion in the loxP-Cre model, we first performed fractionation of mammary tissue from days 1 and 10 of lactation (d1L and d10L, respectively). Figure 3A reveals that Xbp1 is dramatically deleted in the floating adipocytes of the XBP1
DAd tissues compared with the stromal-vascular fractions. Second, we performed laser capture microdissection (LCM) of mammary alveoli from d1L tissues and demonstrated that no deletion of Xbp1 occurred in the captured cells ( Figure 3B ), indicating again the adipocyte specificity of the model employed in our study. (F and G) Percent fat (F) and lean mass and fat mass (G) of WT and XBP1 DAd mice (n = 5-11) as measured by dual energy X-ray absorptiometry (DEXA)
analysis.
(legend continued on next page)
Since regulation of lactation through adipocyte XBP1 is a central tenant of our observations, we also performed additional genetic experiments to validate the adipocyte specificity of the effects of XBP1. First, we examined a potential contribution from macrophages because the aP2 promoter can drive gene expression in these cells (Makowski et al., 2001) . For this purpose, we tested the effects of a macrophage-specific deletion of XBP1 in our model using the LysM-driven Cre to delete XBP1 in the myeloid lineage. Loss of macrophage XBP1 did not affect pup growth during lactation, ruling out a contribution of these cells to the phenotype ( Figure 3C ). Next, we utilized a second, independent adipocyte-specific XBP1-deletion model with Cre expression driven by the Adiponectin promoter (Eguchi et al., 2011) . Importantly, litters from these XBP1 DAd dams also displayed significantly decreased growth during lactation compared with the litters of WT dams ( Figure 3D ). We next examined WT and XBP1 DAd mammary glands for morphological or developmental differences. In virgin mice, we observed slightly reduced mammary gland branching postpuberty in XBP1 DAd glands compared with WT. However, when mammary epithelia from XBP1 DAd glands were isolated and transplanted into a WT recipient fat pad, mammary gland branching was indistinguishable between the genotypes (Figures S3A and S3B) , indicating again that it is the XBP1-deleted adipose tissue in our model that influences the mammary gland environment. Next, we analyzed tissue weights and used a whole-mount staining technique to visualize the development of the mammary epithelia and alveoli during lactation. In these experiments, we did not observe any differences in tissue weight, morphology, or extent of development in the XBP1
DAd glands compared with WT controls (Figures 3E and 3F ). Cross-sections of the tissues stained by H&E also showed similar mammary development in the WT and XBP1 DAd tissues ( Figure S3C ). We also did not observe any large cytoplasmic lipid droplets apparent in the alveolar epithelium, which would indicate a secretory defect. Finally, as a marker of prolactin action, we measured Stat5 signaling in lactating mammary gland tissues from WT and XBP1 DAd mice, and observed no significant differences between the genotypes (Figures S3D and S3E) . Hence, the data obtained thus far suggest normal mammary gland function in XBP1 DAd dams. In sum, the results obtained from examination of tissues, ex vivo investigations, and multiple independent, tissue-specific deletion models in vivo demonstrate that XBP1 deletion in the adipocyte is the causative manipulation that produces a disturbed lactational metabolism.
Analysis of Milk Composition and Quantity in XBP1
DAd
Dams
Since adipose tissue lipids are partitioned to the mammary gland during lactation, it was possible that the gonadal accumulation of lipid in XBP1
DAd dams would affect milk composition. We performed a lipidomic analysis of the major lipid classes and fatty acid composition of those classes in milk produced from each genotype. No significant differences were found among the studied lipid classes in XBP1 DAd milk compared with WT ( Figures 4A, 4B , and S4A). Additionally, fatty acid composition was not altered in XBP1 DAd milk ( Figure 4C ) and cluster analysis did not indicate inherent differences even when the whole data set was incorporated into the comparisons ( Figure S4B ). We also measured lactose and total protein levels in XBP1 DAd milk and found that they were similar to those in WT milk ( Figures  4D and 4E ). Silver staining of milk proteins also did not reveal any gross differences ( Figure S4C ). Therefore, all of the major components tested showed no effect on milk composition in XBP1 DAd dams that would support a content-related defect.
Hence, we moved on to test whether the amount of milk produced was affected by adipocyte deletion of XBP1. Indeed, when we measured milk quantity in pups before and after controlled feeding, we found that the XBP1 DAd dams produced significantly decreased amounts of milk compared with WT controls ( Figure 4F ). This reduction in milk production was unlikely to result from a lack of sufficient prolactin release upon suckling, since serum prolactin levels in the lactating dams were not different between genotypes ( Figure 4G ). Decreased milk volume can be associated with a reduction in mammary gland lipogenesis (Boxer et al., 2006) . Therefore, we examined lipogenic enzymes in lactating mammary glands of WT and XBP1
DAd dams. Our analysis revealed no significant differences in the mRNA levels of the lipogenic genes Fas, Scd1, and Dgat2, and similar protein levels of FAS, SCD1, ACC, and ACLY in WT and XBP1 DAd dams ( Figures S4D and S4E ). In addition, we measured phosphorylation of the lipogenic enzymes ACC and ACL to assess pathway activity and observed no significant differences between genotypes ( Figures S4E and S4F ). Hence, with the measures employed in this study, XBP1 DAd mammary gland lipogenesis appears normal. In sum, although the mechanism underlying the reduced milk volume in the XBP1 DAd dams is unclear at present, we conclude that adipocyte deletion of XBP1 does not impact milk composition but results in decreased milk production during lactation.
XBP1 Regulates the Lipogenic Program in Adipocytes
Although the particular role of the adipocyte during lactation has not yet been defined, it has long been appreciated that adipose tissue must moderate lipogenesis and lipid storage activities in order to direct dietary nutrients to the mammary gland to support milk production. The adipocytes themselves show decreased lipid uptake and lipogenic activity for the sake of redirecting nutrients to the milk-producing secretory cells (Bell and Bauman, 1997; Vernon and Pond, 1997) . In more specific studies investigating the effects of prolactin on adipocytes, the results have been inconsistent and often species dependent (Ben-Jonathan (E) Representative images from CT scans of WT and XBP1 DAd dams during peak lactation (d12L). Adipose tissue density is displayed.
(F) Serum insulin and leptin levels of WT and XBP1 DAd dams at d20L (n = 3).
(G) Pup weights of litters nursed by WT or XBP1 DAd dams during lactation. All litters are mixtures of pup genotypes (WT and XBP1
DAd
; n = 6-10 litters per genotype). (H) Cross-fostering of XBP1
DAd and WT litters. Average pup weight during lactation from cross-fostered litters switched on d1L (n = 8-10, litters were pared to six pups). All error bars indicate ±SEM. *p < 0.05, **p < 0.01 using standard t test; yp < 0.007 as measured by regular two-way ANOVA. See also Figure S2 . et al., 2008) . For instance, it is thought that prolactin does not affect lipolysis in mice. Indeed, when we treated adipose tissue explants with prolactin, we also did not observe a lipolytic effect of prolactin, or any differences between WT and XBP1 DAd in terms of lipolytic activity ( Figures S4G and S4H ). Prolactin has also been reported to decrease glucose uptake in rodent adipocytes and reduce expression of the lipogenic gene fatty acid synthase (FAS; Flint et al., 2003; Hogan and Stephens, 2005) , hypothetically leading to less lipogenesis and nutrient redirection to the mammary gland. We reasoned that since XBP1 is regulated by prolactin in adipocytes and is also involved in lipid metabolism in the liver (Deng et al., 2013; Lee et al., 2008; Wang et al., 2012) , it might be involved in the regulation of the adipocyte lipogenic program during lactation. To investigate the function of XBP1 (D) Average pup weights of litters nursed by WT and Adiponectin Cre XBP1 DAd dams throughout lactation (n = 5-6).
(E) Mammary gland wet weights of WT and XBP1 DAd dams (n = 4-9).
(F) Whole-mount stains of mammary glands from WT and XBP1 DAd mice at different stages of mammary development (NonPG, d1L, or d10L).
All error bars indicate ±SEM; *p < 0.05, standard t test. See also Figure S3 . (F) Milk quantitation assay. The amount of milk produced from each dam was measured as the difference in pup weight before and after a controlled 1.5 hr feeding. Litters were pared to six pups. *p < 0.02 by standard t test.
(legend continued on next page) in adipocytes, we first overexpressed sXBP1, which resulted in the expected upregulation of XBP1 target genes such as Sec61 and Dnajc3, validating our experimental system (Figure 4H ). Of note, sXBP1 expression in adipocytes resulted in a broad downregulation of lipogenic/lipid-storing genes such as Scd1, Fas, Acc, Dgat1/2, and Llp ( Figure 4H ). Next, we suppressed Xbp1 expression in adipocytes through a viral small hairpin RNA (shRNA) and examined the effect of prolactin on a key lipogenic enzyme, stearyl CoA desaturase 1 (SCD1). Interestingly, prolactin treatment caused an increase in SCD1 protein expression in shXBP1 cells ( Figures 4I and 4J ). We also tested these observations in vivo. Importantly, gonadal adipose tissue from XBP1 DAd dams during lactation showed higher levels of FAS and SCD1 proteins ( Figure 4K ), consistent with the data from prolactin-treated adipocytes in vitro. These data indicate that XBP1 may be a critical factor in prolactin-mediated effects on adipocytes given its regulation and requirement for suppressing lipogenic genes in a prolactin-rich environment.
DISCUSSION
The adipocyte is an extraordinary cell type that is poised to act at the intersection of energy supply and demand. Although it can harbor extreme lipid stores under conditions of energy surplus, such as obesity, the adipocyte can also liberate these stores dramatically when called upon by the demand of the organism, such as during lactation. We were surprised to find that although the UPR transcription factor XBP1 can influence in vitro differentiation, adipocyte formation and function were not altered when XBP1 was deleted in adipocytes in vivo, under either normal or HFD conditions. Although obesity induces UPR activation in adipose tissue, it may be that under metabolic stress, other UPR branches compensate for the loss of XBP1, and this results in little to no phenotype (Hotamisligil, 2010) . Indeed, it is possible that XBP1 plays a smaller role in the UPR response of the obese adipocyte but has a distinct role in other processes that demand extreme fluctuations of adipose depots and their function. Supporting this claim, deletion of adipocyte XBP1 resulted in increased maternal adipose tissue, reduced milk production, and reduced weight gain in XBP1 DAd litters during lactation. Furthermore, we showed that prolactin induces XBP1 expression, and suggest that in response to prolactin, XBP1 functions in adipocytes to maintain a low-level lipogenic activity. We postulate that without XBP1, adipose tissue accumulates lipid during lactation; milk production is then deprived of this energy, and this results in less milk and therefore less weight gain for the pups. Interestingly, poor lactation performance is associated with increased adiposity or obesity in women and also in cows (referred to as ''fat cow syndrome''; Rasmussen, 2007) . However, the biological mechanisms underlying these observations remain enigmatic. Decreased pup weight resulting from a lactation defect has been linked to low triglyceride levels or increased viscosity of the milk making it difficult to release (Schwertfeger et al., 2003; Zhu et al., 2005) . Others have reported a similar composition but decreased volume of milk attributable to decreased mammary gland lipogenic activity (Boxer et al., 2006; Rudolph et al., 2010) . We have not seen any alterations in milk composition or evidence of decreased lipogenic activity in the mammary gland, but further investigation of these aspects may be worthwhile. Therefore, we suggest that mammary gland function may be unchanged in XBP1
DAd mice, and that signals from adipose tissue are needed to maintain the level of production of milk but not the gland's developmental or functional integrity. Interestingly, two hormonal signals, insulin and leptin, are elevated in the serum of XBP1 DAd dams during lactation and these hormones are also increased in obese women. Therefore, it would be worthwhile to investigate the effects of the mother's hormonal milieu on milk production. It is also possible that other actions of XBP1, such as synthesis and secretion of an unknown mediator to the mammary gland or an immunological response, could be involved in the effect of adipocyte function during lactation. Thus, we suggest that this work introduces a new context in which to study adipocyte function and biology, as well as UPR, given that the majority of studies involving adipocytes have focused on metabolic homeostasis. Here we reveal the adipocyte's influence on the directional or homeorhetic metabolism of lactation. We anticipate that future studies will uncover further essential adipocyte functions in this vital process of early mammalian growth and survival.
EXPERIMENTAL PROCEDURES Generation and Breeding of XBP1
DAd Mice C57BL/6 mice harboring loxP sites around exon 2 of XBP1 (Lee et al., 2008) were crossed to mice carrying the Cre recombinase gene under aP2, adiponectin, or LysM promoters (all three of the C57BL/6 genetic background). A breeding strategy was followed to ensure that control (XBP1 flox/flox-no Cre) and experimental mice (XBP1flox/flox-Cre) were always littermates. (J) Graph of densitometry data for protein levels of SCD1 in cultured adipocytes during low or high (50-500 ng/ml) prolactin treatments. SCD1 protein levels were normalized to adiponectin. The basal WT SCD1 protein level was set at 1. (K) Western blot analysis of FAS, SCD1, and Tubulin proteins in gonadal adipose tissue from WT and XBP1 DAd mice at d10L. Densitometry measures are provided in the graph to the right. All error bars indicate ±SEM. *p < 0.05, **p < 0.004 using standard t test; yp < 0.004 as measured by regular two-way ANOVA. See also Figure S4 .
the Arcturus PixCell II instrument along with Macro CapSure Caps (Molecular Devices). For each animal, one slide of two serial sections was captured for 50-60 min with a laser beam size of 7.5 mm and power of 50 mW. RNA extraction of the isolated cells was performed using the PicoPure RNA Isolation kit (Molecular Devices) and complementary DNA (cDNA) was synthesized from the total RNA extracted (Fermentas). The levels of deleted (primers specific to exon 2) and total (primers not in exon 2) Xbp1 mRNA were assessed by quantitative RT-PCR (qRT-PCR).
Preparation of Mammary Gland Whole Mounts
Whole-mount preparations of mammary glands were performed according to the protocol found on the NIH Biology of the Mammary Gland website (http:// mammary.nih.gov/tools/histological/Histology/index.html). Briefly, inguinal #4 mammary glands were dissected, spread on glass slides, and fixed overnight in Carnoy's fixative. The next day, the tissues were hydrated and then stained in carmine-aluminum stain overnight. The tissues were dehydrated, cleared in xylene, and mounted between two glass slides using Permount mounting media.
Adipocyte Cell Culture 3T3L1 and F442A preadipocytes were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% bovine calf serum. To induce differentiation, 3T3L1 cells were grown to confluence and fed induction medium (DMEM, 10% cosmic calf serum [CCS], 5 mg/ml insulin, 0.5 mM 3-isobutyl-1-methylxanthine [IBMX], 1 mM dexamethasone, with or without 10 mM rosiglitazone). After 2 days, the medium was changed to DMEM, 10% CCS, and 5 mg/ml insulin. F442A cells were differentiated in only the DMEM-CCS-insulin medium. Adipocytes were considered fully differentiated at day 8.
CT Scan Imaging
Mice at d12L were anesthetized and scanned using the GE Explore CT 120 Micro-CT scanner. Data capture and reconstructions of the adipose tissue were done using Osirix software.
Milk Collection and Analysis
Following overnight pup removal to facilitate milk accumulation, mice were anesthetized at d12L. Milk was collected by gentle manual nipple stimulation. Lactose was measured per kit instructions (Abcam) and total protein was measured via the DC Protein Assay (Bio-Rad). Lipid extraction was done on a 5 ml sample of milk, and triglyceride and free fatty acid content was determined using Sigma and WAKO diagnostics assays, respectively. In-depth lipidomics analysis was performed as described previously (Cao et al., 2008) by Lipomics (Sacramento, CA).
Milk Quantitation
Quantitation of milk production was performed as previously described (Jara-Almonte and White, 1972). In brief, 10-day-old pups were removed from dams and fasted for 6 hr. The pups were then returned to the dams for 1.5 hr and litter weights were taken before (postfast) and after milking. The difference in litter weight represents the amount of milk consumed. For further details regarding the materials and methods used in this work, see Extended Experimental Procedures.
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